Myrobalan Therapeutics Awarded a Grant from the National Multiple Sclerosis Society to Advance Development of MRO-002 in Multiple Sclerosis
Myrobalan to receive over $850,000 in funding to advance the development of its GPR17 antagonist for progressive MS from the ...
The Brighterside of News on MSN6h
Breakthrough new drug can restore human vision loss, study finds
Myelin, the protective sheath around nerve fibers, plays a crucial role in brain communication. It ensures fast and efficient ...
Labroots8h
Antibodies Against Epstein-Barr Virus Increase Risk of Multiple Sclerosis
The Epstein-Barr virus (EBV) is one of the most common human viruses worldwide. According to the Centers for Disease Control and Prevention (CDC), EBV can | Immunology ...